Across TCGA pan-cancer cohorts, ZNF736P2Y RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated ZNF736P2Y data layer.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher ZNF736P2Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF736P2Y expression acts as an unfavorable survival marker.
BRCA are the cancer types where ZNF736P2Y RNA most reproducibly stratifies survival.